Poster #34: Isabelle Schlegel – Peptide-Antibody Conjugates to Treat Macular Degeneration

<< Return to the Virtual URS Main Page

Faculty mentor: Michael Yu

Neovascular Age-Related Macular Degeneration is a chronic eye disease caused by over-expression of VEGF and treated with eye injections of VEGF-binding Ranibizumab (fab). The fab’s short ocular half-life leads to poor patient compliance. We attached hyaluronic acid (HA) and collagen (col) targeting peptides to the fab to target HA and col in the vitreous. We demonstrated high binding affinity of our conjugates for HA and col as well as VEGF, showing that our conjugates may extend fab half-life.

Click below to hear me present my poster!
Questions or comments? Contact me at: remus.kitty@gmail.com

 

<< Return to the Virtual URS Main Page